|
|
|
- えの いとえ
- 9 years ago
- Views:
Transcription
1
2
3
4
5
6 60 etc.
7
8
9
10
11 23.5% 2.8% 2.8% 3.4% 30.3% 9.9% 11.5% 15.8%
12
13
14
15
16
17 AAN n=985 n=495 n=490 n=490 %
18
19
20 / / -/ NIPPON DATA 80
21 / / -/ NIPPON DATA 80
22 / -/ NIPPON DATA 80
23
24 UK Small Aneurysm Trial The Edinburgh Artery Study The Cardiovascular Health Study
25 COPD CT
26 COPD
27 Influenza-like disease Healthy Total Mild Moderate Severe Total smoker Number (%) non-smoker Number (%) 36 ( 60%) 47 (41.6%) 24 ( 40%) 66 (58.4%) 60 (100%) 113 (100 %) (16.7%) 18 (38.3%) 14 (38.9%) 8 (17.0%) 16 (44.4%) 21 (44.7%) 36 (100 %) 47 (100 %) Kark JD, Lebiush M. Am J of Public Health 71 :
28 Nuorti JP et al. Cigarette Smoking and Invasive Pneumococcal Disease. N Engl J Med. 2000;342: Lidia Arcavi et al. Cigarette Smoking and Infection. Arch Intern Med. 2004;164:
29 23.5% 2.8% 2.8% 3.4% 30.3% 9.9% 11.5% 15.8%
30
31 cm cm cm mmHg and/or mmhg 110mg /dl TG 150mg /dl and/or HDL-C 40mg /dl
32 GLUT-4 AT- TNF glucose GLUT-4
33 Iwashima Y, Katsuya T et.al. Hypertension Jun;45(6):
34 Hypertension Jun;45(6):
35 Foy Capri G, Bell RA et.al. Diabetes Care 28: , 2005 OGTT Findings form the Insulin Resistance Atherosclerosis Study (IRAS) Normal Glucose Tolerance N=593 Impaired Glucose Tolerance N=295
36 TNF TNF FFA Liu RH, Mizuta M, Matsukura S : J Pharmacol Exp Ther Jul;310(1):52-8
37
38 HP
39
40 COPD
41
42 2007 :
43 10 10 Doll R, et al. BMJ 2004;328: Survival from age 35 for continuing cigarette smokers and lifelong non-smokers among UK male doctors born , with percentages alive at each decade of age Copyright 2004 BMJ Publishing Group Ltd. Age(years)
44 70 70 R. Doll et al BMJ 1994;309: Mortality in relation to smoking:40 years' observations on male British doctors
45
46 Sundstrom J,et al. Clinical value of the metabolic syndrome for long term prediction of total and cardiovascular mortality: prospective, population based cohort study. BMJ. 332:878-82,2006.
47
48 etc.
49 Weitzman M et al: Pediatrics Apr;85(4): Maternal smoking and childhood asthma. n= Infante-Rivard C et al: Am J Epidemiol Sep 1;150(5): Maternal smoking and childhood asthma. n=
50 n=149 < 10 / 10 / < n Morkjaroenpong V et al:j Allergy Clin Immunol 110(1): ,2002.
51 COPD HDAC HDAC Kazuhiro Ito et al: N Engl J Med 2005;353(5):528.
52
53 WHO Report on the Global Tobacco Epidemic, 2008
54 FCTC Framework Convention on Tobacco Control WHO COP3 COP : conference of the parties FCCC Framework Convention on Climate Change. CO2 CO COP15
55
56 N.Y. N.Y. etc. 27,000 27, ,
57
58 FDA FDA WHO WHO
59
60
61 a 0-
62
63
64 ETS Environmental Tobacco Smoke SHS Second Hand Tobacco Smoke IARC EPA EPA IARC A
65 Pell JP et al. Smoke-free legislation and hospitalizations for acute coronary syndrome. N Engl J Med 2008;359:482-91
66
67 JT 50% JT 50% JT 50.02% 2.46% 1.85% 1.51% 1.35% JT NY
68 !
69 JT JT JT JT JT JT
70 JT JT JT
71 Why Review Articles on the Health Effects of Passive Smoking Reach Different Conclusions Deborah E. Barnes et al. JAMA. 279: % %
72
73 EU
74 EU
75 EU
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91 58 40 / 40 TDS 10 CO 34ppm
92 58
93 42 30 / 20 TDS 6 CO 9ppm HP JT
94 42 JT
95 25 20 / 10 TDS 9 7 CO 24 18
96 25
97
98 * Merry Christmas!
untitled
5 K 5 3 HP http://www.mhlw.go.jp/bunya/shakaihosho/iryouseido01/taikou03.html 2004 1 2 1 http://www.dm-net.co.jp/calendar/2007/06/005835.php 6 85cm 100cm 2 90cm 2 TG 150mg/dl HDLHDL-C 40mg/dl 130mmHg 85mmHg
C/NC : committed/noncommitted
C/NC : committed/noncommitted 110 time post-icd implant 1) The Cardiac Arrhythmia Suppression Trial (CAST) Investigators Preliminary report : Effect of encainaide and flecainide on mortality in a
.}.u
March WHO Framework Convention on Tobacco ControlFCTC Japan Tobacco Inc., JT JT WHO A WHO FCTC JARO March JT CM CM a b DVD c a b FCTC JT March WHO FCTC WHO FCTC FCTC FCTC FCTC Mary Assunta and Simon Chapam,
14 12 10 8 6 4 2 0 1 2 3 4 5 6 7 8 9 10 11 12 20 0 0 0 0 0 0 0 0 0 0 0 0 21 0 0 0 0 0 0 0 0 0 0 0 0 22 0 0 0 0 0 0 0 0 0 0 0 0 23 0 0 0 0 0 0 0 0 0 0 0 0 24 0 0 0 0 0 0 0 0 0 0 0 0 25 0 0 0 0 0 0 0 0 0
37, 9-14, 2017 : cefcapene piperacillin 3 CT Clostridium difficile CD vancomycin CD 7 Clostridium difficile CD CD associate
37, 9-14, 2017 : 36 2015 8 6 cefcapene piperacillin 3 CT Clostridium difficile CD vancomycin 20 1983 2016 3 CD 7 Clostridium difficile CD CD associated diarrhea : CDAD CD 1,2 PPI 3 1 36 33 2015 8 6 5 5
日本皮膚科学会雑誌第121巻第11号
β Clin Rheumatol Arthritis Rheum Am J Cardiol J Rheumatol J Rheumatol Arthritis Rheum Arthritis Rheum Arthritis Rheum Rheumatology Oxford Rheumatology Oxford Br J Dermatol Arch Dermatol Ann Rheum Dis
The Heart Healthy Tocotrienol Complex Tocomin SupraBio
The Heart Healthy Tocotrienol Complex Tocomin SupraBio The Heart Healthy Tocotrienol Complex Tocomin SupraBio 1. Fact Sheet No. 317; World Health Organization (WHO), 2007 2. LLOYD-JONES D. et al. Circulation
BAANs理論に基づく保健指導プログラム暫定版
WHO 4 5 10% L- -3 RNA L - 1960-3 RNA mrna Bio Activating Advanced Nutrients BAANs BAANs BAANs BAANs L- (NO) -3 EPA, DHA) RNA RNA DNA TNF- PAI-1 ( ) BAANs 40 50% 20% 1Kg 7,000Kcal 50Kcal 11 50Kcal
小児感染免疫第27巻第4号
364 2015 C 1 2 3 4 5 6 7 8 urinary tract infection UTI 2 1 UTI 1 3 5 2,3 4 1 UTI Escherichia coli E. coli 80 5 Enterococcus 1 UTI 83 78 53 98 5 WBCs HPF 73 81 81 83 or 93 72 ororor 99.8 70 4 Key words
Complex sleep apnea syndrome and sleep disordered breathing in patients with cardiovascular disease V o l. 4 1 N o. 3 ( 2 0 0 9 ) V o l. 4 1 N o. 3 ( 2 0 0 9 ) V o l. 4 1 N o. 3 ( 2 0 0 9 ) Sleep J Clin
ブック 1.indb
21 1211 27 11 27 12 16 20 11 27 10 20 28 29 30 12 10 11 12 30 13 30 14 10 30 15 11 16 12 17 13 18 14 19 15 20 16 10 21 11 27 106 21 107 108 109 110 21 111 28 112 28 10 113 29 11 11421 30 12 11521 32 13
CSR報告書2005 (和文)
A 250 200 150 100 50 0 25,000 20,000 15,000 10,000 5,000 0 1,000 800 600 400 200 0 168 14 14 27 54 60 2000 16,975 1,314 1,207 8,977 5,477 2000 698 112 115 292 178 2000 223 24 28
437“ƒ
et al., et al., et al., et al., et al., et al., 2 et al., et al., et al., Lancet Pharmacol Res. et al. Jpn J Cancer Res. et al. Jpn J Cancer Res. et al. Tohoku J Exp Med. et al. Jpn Circ J. et al. Cancer
＠０８４６００２５ヨコ／伊東 ２１７号
A B B A B A B A B stratification inequality Marmot, Smith, Why are the Japanese living longer?, British Medical Journal, 1989 Kondo, Kawachi, Subramanian, Takeda, Yamagata Do social comparisons
どうしてタバコはダメなのか? ~ 未来の子供たちのために ~ uicc 東京都医師会タバコ対策委員会
どうしてタバコはダメなのか? ~ 未来の子供たちのために ~ uicc 東京都医師会タバコ対策委員会 タバコを吸って病気になると 幸せな生活が一瞬にして壊されます 家族に大きな経済的負担をかけます 看護や介護で肉体的負担もかけます 精神的にも大きな負担がかかります ( 家族たちに受動喫煙をさせています ) ( 子供たちもマネをして吸い始めます ) 禁煙できない医師すら存在します どうして医師ですら吸うのでしょう?
! 1Munderl P et al. Survival and causes of death, 2 years after Introduction of antiretroviral therapy in Africa. XVI International AIDS Conference, 2006, Abstract THLB0208. 2Walensky RP et al. The
審査報告書（案）
19 83 7 18 628 1 19 8 3 7 18 6 28 30 MI 31 360 21700BZY00247000 5mm CEA 59 mm 2 50% 80 1. 2. 3 19 8 3 [ ] 7 [ ] [ ] [ ] [ ] 18 6 28 [ ] CEA 49mm 50 80 2 4 carotid endarterectomy CEA 1,2 CEA ECST 3 NASCET
E Societe de Pathologie Infectieuse de Langue Francaise (, 1991) E Spanish Thoracic Society (1992) E American Thoracic Society (ATS : 1993. ü ù2001 ) E British Thoracic Society (1993, ü è2001 ) E Canadian
Key words : Adverse reactions, Egg allergy, IgG antibody, Mills allergy, FAST
Key words : Adverse reactions, Egg allergy, IgG antibody, Mills allergy, FAST 13) Danaeus, A., Johansson, S. G. O., Foucard, T. & Ohman, S.: Clinical and immunogical aspects of food allergy in childhood.
untitled
2005 10 13 Dr. RGA 19602000 10 Australian Institute of of Health and and Welfare 2004 ABS Cat. Cat. No. No. 3201.0; AIHW National Population Database 1875 2 211997 8 122164 http://www.wowzone.com/calment.htm
名称未設定-1
Study on Clinical Factors Affecting the Fungal Culture Test - Relevance of Dry Mouth - Yoshiko YAMAMURA, Yukihiro MOMOTA, Hideyuki TAKANO, Koichi KANI, Katsumi MOTEGI, Fumihiro MATSUMOTO, Masayuki AZUMA
H29_第40集_大和証券_研究業績_C本文_p indd
慢性腎臓病 (CKD) における危険因子としての食後高血糖の検討 独立行政法人国立病院機構千葉東病院臨床研究部 糖尿病研究室長関直人 はじめに 1. 研究の背景慢性腎臓病 (CKD) は 動脈硬化 腎機能低下 末期腎不全 心血管イベントなどの危険因子であることが報告されている (1) 一方で食後高血糖もまた 動脈硬化 心血管イベントの危険因子であることが報告されている (2) 食後高血糖の検出には持続血糖モニタリング
1) University Group Diabetes Program: A study of hypoglycemic agents on vascular complica- in patients with adult-onset tions diabetes. I. Design, methods and baseline results. Diabetes 19 (suppl. 2):
日本化学療法学会雑誌第58巻第2号
Key words β Candida Table1. MCFGCPAstudygroup Investigator (representative) YoshitsuguMiyazaki NaoyukiMiyashita RyoichiAmitani KenjiOgawa AtsuyukiKurashima ToshiroKiguchi MichiakiMishima YuichiInoue HiroshiSaito
WHO Library Cataloguing in Publication Data 2003, Wilkinson,Richard Marmot,Michael Social determinants of health SDH The social gradient Stress Early life Social exclusion Work Unemployment Social support
mg 8 mg X Cr 9.84 mg/ dl K 1.5 meq/l CK 24,570 U/L Mb 79,530 ng/ml Mb 230,000 ng/ ml AKI 2 IHD IHD 4 IHD
31 1 15 20 2016 15 3 65 5 mg 8 mg 10 15 201X 7 1 11 15 Cr 9.84 mg/ dl K 1.5 meq/l CK 24,570 U/L Mb 79,530 ng/ml Mb 230,000 ng/ ml AKI 2 IHD IHD 4 IHD AKI HD 2004 48 Acute Kidney Injury AKI 48 Cr 0.3 mg/dl
「諸雑公文書」整理の中間報告
30 10 3 from to 10 from to ( ) ( ) 20 20 20 20 20 35 8 39 11 41 10 41 9 41 7 43 13 41 11 42 7 42 11 41 7 42 10 4 4 8 4 30 10 ( ) ( ) 17 23 5 11 5 8 8 11 11 13 14 15 16 17 121 767 1,225 2.9 18.7 29.8 3.9
164 SDD & SOD SDD E100 mg 80 mg B500 mg 2 E 2 B 48 /59 81 SDD SOD 10 /63 16 RCT RCT 1992 Gastinne 15 ICU 445 SDD E100 mg 80 mg B 10
163 特 集 SDD & SOD SDD(Selective digestive decontamination),sod(selective oropharynx decontamination), 腸内細菌叢, 耐性菌 Ⅰ はじめに SDD Selective digestive decontamination SOD Selective oropharynx decontamination
1 2 D- D- 1206 D- D- -2003 120 /2004 D-FDA GRAS D D- 3 5 5 D- 75 10g/kg 14 40 20 D-101520 90 1520 20%101520 1520 D- 5(D- 2300-6700mg//) () 2024 615 D- 41220g/kg/ 1220g/kg/ 20g/kg/ 1220g/kg/ () 50 D- 10%
WHO Framework Convention on Tobacco ControlWHOFCTC IT A 1106 Circulation Journal Vol. 69, Suppl. IV, 2005
20032004 Smoking Cessation Guideline (JCS 2005) 50 1 1 2 3 4 5 2 1 2 3 4 5 6 3 Circulation Journal Vol. 69, Suppl. IV, 2005 1105 20032004 1 2003 5 WHO Framework Convention on Tobacco ControlWHOFCTC 1 2
第124回日本医学会シンポジウム
III γ γ γ α γ Molecular Mechanism of Insulin Resistance by Adipocytes TAKASHI KADOWAKI Department of Metabolic Diseases, Graduate School of Medicine, University of Tokyo Key words γ 110 124 TNFα FFA 1,2
特殊病態下感染症における抗菌薬治験の手引き作成委員会報告書（案）
VOL.51 NO.6 JUNE 2003 JUNE 2003 9) Niederman MS et al: Guidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy and prevention.
診療ガイドラインのカラクリ
EBM EBM 2-3 (evidence-based medicine: EBM) EBM 1 1 1 2 B burden belief bargain barrier A. JAMA EBMer JAMA EBM 3 EBM 3 EBM 3 3 B. peer review Field(IOM) Shaneyfelt ( Guidelines Qualities Assessment Questionnaire:
HPV HPV HPV HPV 7 HPV 8 9 HPV 3 HPV HPV HPV , Becker Ajzen H
3 26 3 Journal of Junshin Gakuen University, HPV Faculty of Health Sciences Vol.3, March 2014 99 HPV Knowledge of and attitudes towards human papillomavirus vaccinations among mothers who have daughters
Fig. 1 Clinical findings and extent of inflammation area in female urethrocystitis Fig. 2 Classification and distribution of female patients with blad
Key words: Female with bladder irritability, Subjective symptoms, Pyuria, Bacteriuria Fig. 1 Clinical findings and extent of inflammation area in female urethrocystitis Fig. 2 Classification and distribution
食道がん化学放射線療法後のsalvage手術
2006 2 17 52 Daly JM, et al. J Am Coll Surg 2000;190:562-573 Esophageal Cancer: Results of an American College of Surgeons Patient Care Evaluation Study Daly JM, et al. J Am Coll Surg 2000;190:562-573
終末期の呼吸困難症状への対応*松坂最終修正
Clinical Question 2017 5 27 1 PCOC 1. 12778 ( 55%, 45% NRS. 1 54, 35%. NRS. NRS,,,,,,,, Performance status, Ekstrom, M., et al.2016 J Pain Symptom Manage 51(5):816-23. . 1 85 ADL. 3,,,,. JCS200,, 40 /,
8 8.1 Lieberman; db Kisilevsky; 1989 Hartikainen; db 90 db Ando & Hattori; 1973 Suzuki & Kabuto; ,000 2,500g 13 Lagers
8 8.1 Lieberman; 1975 100 105 db Kisilevsky; 1989 Hartikainen; 1994 78 db 90 db Ando & Hattori; 1973 Suzuki & Kabuto; 1978 713 40,000 2,500g 13 Lagerstrom et al.; 1991 Rantakallio; 1985, McDermott et al.;
CHEMOTHERAPY AUG. 1982 VOL. 30 NO. 8 CHEMOTHERAPY Fig.1 Relation between various-closis of cefazolin and detection rate of organisms in heart blood of dying mice with E. coli and P. aeruginosa infection
8 The Bulletin of Meiji University of Integrative Medicine API II 61 ASO X 11 7 X-4 6 X m 5 X-2 4 X 3 9 X 11 7 API 0.84 ASO X 1 1 MR-angio
7-14 2010 1 1 1 2 1 1 1 2 Fontaine II ASO61 3 API ASO ASO ASO API API KKKKKKKKKK ASO Fontaine II API Received April 14, 2009; Accepted July 16, 2009 I arteriosclerosis obliterans: ASO ASO 50 70 1,2 Fontaine
,977 t 157,977 t mg l mg l BOD 9398 % OH = cm 3 / sec 11 = cm 3 / sec OH = /
1 9625 2219 CAS 75569 1, 2-1, 2- H 2 C CH CH 3 C 3 H 6 O 58.08 1 99 % 1. 2 2, 3-112.13 2, 3 34.23-37 449 2.8-37 % 2 d 0 4 0.859 4 d 20 0.8304 2 2, 4 2.00 = 1 53.33 kpa 400 mmhg18 59.33 kpa 445 mmhg20 5
求人面接資料PPT
Hair Salon TV etc. 250" 250" 200" 200" 150" 150" 100" 100" 50" 50" 0" 0" Nov)13" Dec)13" Jan)14" Feb)14" Mar)14" Apr)14" May)14" Jun)14" Jul)14" Dec)12" Jan)13" Feb)13" Mar)13" Apr)13"
JAGES 1 http://www.mlit.go.jp/common/000135841.pdf http://www.mhlw.go.jp/file/04-houdouhappyou-12004000-shakaiengokyoku-shakai-fukushikibanka/270624houdou.pdf_2.pdf 21 59 10 vs 9 8,500 8,000 7,500 7,000
本文／一般演題＿吉田
184 quality of lifeqol mmhg Hb gdl CA Uml Niveau Hb Hb gdl RCC CT MRI T 185 CT A B MRI A:T B:T Douglas red spot S ml RCC 186 A B mg CAUml S MRI A B 187 188 S mg Sampson JA. Intestinal adenomas of endometriosis
BUN, CRP K mg/ cm, 49.6 kg, BMI /72 mmhg, 92/ Hb 6.7 g/dl PT-INR CT 1 MRI 2a, b T1 T2 T1 MRI
20 2 2015 1 2 3 85 K CT Abstract A case of renal subcapsular hematoma resulting from trigger point injection under excessive effect of anticoagulant YAMANE Tateki, UMEDA Akira and SHIMAO Hitoshi An 85-year-old
98-02.PDF
1 982 2207 CAS 67630 2- H 3 C H 3 C CH OH C 3 H 8 O 60.10 1 99.9 % n- 1. 2-88.5 3 82.5 3 11.7c.c. 455 4 212 d 20 4 0.78505 3 2.1 = 1 4 4.4 kpa 33 mmhg20 4 log Pow0.05 0.07 5 m/z45, 1.0 43 0.19 27 0.17
Influences of mortality from main causes of death on life expectancy. \ An observation for the past 25 years, 1950-1975, in Japan \ Takao SHIGEMATSU* and Zenji NANJO** With the Keyfitz-Nanjo method an
Table 1 Characteristics of the study participants in Imari municipal hospital
Key words: tuberculosis, booster phenomenon, two-step tuberculin test Table 1 Characteristics of the study participants in Imari municipal hospital Fig. 1 Frequency distributions of size of the first tuberculin